Dowpharma Case Study: Implementing a Technology Transfer for a New Product Using a CMO

Share Article

Improving speed to market is critical in the pharmaceutical industry. Using a CMO is an effective strategy to ensure this outcome. Jeff Dudley from Dowpharma and Dow Ventures discusses the pros and cons of implementing a technology transfer for a new product using a CMO.

In a Xtalks Web Conference on Thursday, August 10, 2006, from 11:00am – 12:00pm EDT, Jeff Dudley, Business Operations Director, Dowpharma and Dow Ventures presents a case study on implementing a technology transfer for a new product using a CMO (Contract Manufacturing Organization).

Register: http://www.xtalks.com/techtransfer.ashx
Ensuring Quality and Efficiency in Technology Transfer

Improving speed to market is critical to gain market share and increase profitability. An effective strategy to ensure this outcome is to outsource manufacturing operations to a credible CMO. Doing this successfully requires partnering with an experienced CMO that can deliver quality results in the most efficient and cost effective manner.

Join us for this case study and hear Jeff Dudley share his experiences in technology transfer and using a CMO. Points discussed include:

  •     How to promote a successful technology transfer –two sides of a successful technology strategy
  •     What can go wrong on technology transfers
  •     Comparing 2 cases: a successful vs. a failed case
  •     What made one work and not the other?

The Dowpharma Case Study: Implementing a Technology Transfer Web Conference will take place on Thursday, August 10, 2006, from 11:00am – 12:00pm EDT.

Register: http://www.xtalks.com/techtransfer.ashx

The web conference is sponsored by: Dowpharma

Dowpharma, a division of Dow, serves the pharmaceutical and biopharmaceutical industries with innovative technology, products, and services for clients in drug discovery, development, manufacturing and delivery.

Dowpharma offers broad service and support capabilities for both large and emerging pharmaceutical companies. Dowpharma takes a customer-centered approach to custom manufacturing, which results in an intense focus for each customer and their specialized needs within a large, diverse and rapidly evolving pharmaceutical industry.

Dow’s Mission: To constantly improve what is essential to human progress by mastering science and technology. http://www.dowpharma.com

About Xtalks

Xtalks (recently featured in the London Times article Conference call that spans the globe: http://business.timesonline.co.uk/article/0,,9075-1364240,00.html) brings industry experts to executives’ desktops around the world in a web-based information network that provides insight into breaking business issues through interactive digital web conferences. Xtalks web conferences allow anyone with interest in a particular topic to participate in a web meeting by synchronizing their desktop computer and phone alongside industry experts. Xtalks is part of The Honeycomb Worldwide Group of Companies.

Honeycomb Worldwide creates peer-to-peer business-oriented social networking communities, connecting senior level executives by delivering content through new and established media channels. http://www.honeycombworldwide.com

For more information on this conference or Xtalks in general, or to enquire about speaking opportunities or sponsoring future events, visit http://www.xtalks.com or contact Karen Anderson, Chief Marketing officer, at 312-977-1166.

Register: http://www.xtalks.com/techtransfer.ashx

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Anderson
XTALKS
312-977-1166
Email >
Visit website